This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rajiv Panwar
Associate Director, Head of Analytical and Formulation Development at Magenta Therapeutics


Dr. Panwar holds MS and PhD degrees in interdisciplinary pharmaceutical sciences from Northeastern University, Boston, where his work was focused on use of antibodies and antibody drug conjugates (ADCs) for molecular imaging and cancer therapy. After graduation, he spent his career at Akrivis technologies, Eleven biotherapeutics and more recently Magenta therapeutics where he has been holding roles of increasing responsibility in analytical, formulation and bioassay development. At Magenta, Dr. Panwar’s team develops and transfers analytical methods and formulations to CDMOs in support of preclinical and clinical development of linker payloads, antibodies and ADCs.  

Agenda Sessions

  • Orthogonal Approaches to Formulation Development of Antibodies and ADCs